Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Trends in the Incidence and Treatment of Cerebrovascular Diseases in Korea : Part II. Cerebral Infarction, Cerebral Arterial Stenosis, and Moyamoya Disease

  • Lee, Si Un (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Kim, Tackeun (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Kwon, O-Ki (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Bang, Jae Seung (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Ban, Seung Pil (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Byoun, Hyoung Soo (Department of Neurosurgery, Seoul National University Bundang Hospital) ;
  • Oh, Chang Wan (Department of Neurosurgery, Seoul National University Bundang Hospital)
  • Received : 2018.09.12
  • Accepted : 2018.11.26
  • Published : 2020.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : To analyze trends in the incidence and treatment of diseases associated with ischemic stroke, namely, cerebral infarction (CI), cerebral arterial stenosis (CASTN), and moyamoya disease (MMD), based on Korean National Health Insurance Service (NHIS) data from 2008 to 2016. Methods : Data was extracted from the national health-claim database provided by the NHIS for 2008-2016 using International Classification of Diseases codes. The crude and age-standardized incidences of each disease (CI, CASTN without a history of CI, and MMD) were calculated; additional analyses were conducted according to age and sex. Trends in the number of patients undergoing treatment according to treatment method were analyzed for each disease using the Korean Classification of Diseases procedure codes. Results : In 2016, the total number of adults with newly diagnosed CI was 83939, reflecting a 9.4% decrease from that in 2008. The age-standardized incidence of CI in adults was 153.2 per 100000 person-years in 2016, reflecting a 37.2% decrease from that in 2008, while that of CASTN was 167.3 per 100000 person-years in 2016, reflecting a 73.3% increase from that in 2008. Among treated cases, the number of patients who underwent intra-arterial (IA) treatment, including IA fibrinolysis and mechanical thrombectomy, showed the most prominent increase, increasing at an annual rate of 25.8%. For CASTN, the number of cases treated with carotid artery stenting or balloon angioplasty (CAS) showed the most prominent increase, increasing at a rate of 69.8% over the 9-year period. For MMD, the total number of patients with newly diagnosed MMD and that with adult MMD demonstrated significantly increasing trends, while the number of pediatric patients with newly diagnosed MMD declined by 18.0% over the 9-year period. The age-standardized incidences of pediatric and adult MMD in 2016 were 2.4 and 3.4 per 100000 person-years, respectively. Conclusion : Although the incidence of CI showed a declining trend over a 9-year period, the number and proportion of patients treated for CI increased. Meanwhile, the incidence of CASTN and the number of patients treated for CASTN have demonstrated increasing trends since 2008. On the other hand, the number of patients diagnosed with pediatric MMD decreased, despite no significant change in the incidence. In contrast, the number of patients and the incidence of adult MMD increased. These trends reflect changes in the population structure, gains in the accessibility of imaging examinations, and the development of endovascular techniques.

Keywords

References

  1. Abbott AL, Paraskevas KI, Kakkos SK, Golledge J, Eckstein HH, Diaz-Sandoval LJ, et al. : Systematic review of guidelines for the management of asymptomatic and symptomatic carotid stenosis. Stroke 46 : 3288-3301, 2015 https://doi.org/10.1161/STROKEAHA.115.003390
  2. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. : Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38 : 1655-1711, 2007 https://doi.org/10.1161/strokeaha.107.181486
  3. Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ, Ahn HS : Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke 45 : 1090-1095, 2014 https://doi.org/10.1161/STROKEAHA.113.004273
  4. Anderson CS, Carter KN, Hackett ML, Feigin V, Barber PA, Broad JB, et al. : Trends in stroke incidence in Auckland, New Zealand, during 1981 to 2003. Stroke 36 : 2087-2093, 2005 https://doi.org/10.1161/01.str.0000181079.42690.bf
  5. Campbell BC, Purushotham A, Christensen S, Desmond PM, Nagakane Y, Parsons MW, et al. : The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab 32 : 50-56, 2012 https://doi.org/10.1038/jcbfm.2011.102
  6. Chen PC, Yang SH, Chien KL, Tsai IJ, Kuo MF : Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study. Stroke 45 : 1258-1263, 2014 https://doi.org/10.1161/STROKEAHA.113.004160
  7. Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, et al. : The warfarin-aspirin symptomatic intracranial disease study. Neurology 45 : 1488-1493, 1995 https://doi.org/10.1212/WNL.45.8.1488
  8. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. : Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365 : 993-1003, 2011 https://doi.org/10.1056/NEJMoa1105335
  9. Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, et al. : Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet 383 : 333-341, 2014 https://doi.org/10.1016/s0140-6736(13)62038-3
  10. Feigin VL, Krishnamurthi RV, Parmar P, Norrving B, Mensah GA, Bennett DA, et al. : Update on the global burden of ischemic and hemorrhagic stroke in 1990-2013: the GBD 2013 study. Neuroepidemiology 45 : 161-176, 2015 https://doi.org/10.1159/000441085
  11. Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, Langenberg P, et al. : Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 40 : 1541-1545, 1990
  12. Felling RJ, Sun LR, Maxwell EC, Goldenberg N, Bernard T : Pediatric arterial ischemic stroke: epidemiology, risk factors, and management. Blood Cells Mol Dis 67 : 23-33, 2017 https://doi.org/10.1016/j.bcmd.2017.03.003
  13. Ferro JM, Massaro AR, Mas JL : Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol 9 : 1085-1096, 2010 https://doi.org/10.1016/S1474-4422(10)70251-9
  14. GBD 2016 Causes of Death Collaborators : Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 : 1151-1210, 2017 https://doi.org/10.1016/S0140-6736(17)32152-9
  15. Gokben S, Tosun A, Bayram N, Serdaroglu G, Polat M, Kavakli K, et al. : Arterial ischemic stroke in childhood: risk factors and outcome in old versus new era. J Child Neurol 22 : 1204-1208, 2007 https://doi.org/10.1177/0883073807307863
  16. Grant PE, He J, Halpern EF, Wu O, Schaefer PW, Schwamm LH, et al. : Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain. Radiology 221 : 43-50, 2001 https://doi.org/10.1148/radiol.2211001523
  17. Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, et al. : Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama study (1961-2009). Circulation 128 : 1198-1205, 2013 https://doi.org/10.1161/CIRCULATIONAHA.113.002424
  18. Hong KS, Bang OY, Kang DW, Yu KH, Bae HJ, Lee JS, et al. : Stroke statistics in Korea: part I. epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke. J Stroke 15 : 2-20, 2013 https://doi.org/10.5853/jos.2013.15.1.2
  19. Imai K, Mori T, Izumoto H, Watanabe M, Majima K : Emergency carotid artery stent placement in patients with acute ischemic stroke. AJNR Am J Neuroradiol 26 : 1249-1258, 2005
  20. Islam MS, Anderson CS, Hankey GJ, Hardie K, Carter K, Broadhurst R, et al. : Trends in incidence and outcome of stroke in Perth, Western Australia during 1989 to 2001: the Perth Community Stroke Study. Stroke 39 : 776-782, 2008 https://doi.org/10.1161/strokeaha.107.493643
  21. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. : Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44 : 870-947, 2013 https://doi.org/10.1161/STR.0b013e318284056a
  22. Kainth D, Chaudhry SA, Kainth H, Suri FK, Qureshi AI : Epidemiological and clinical features of moyamoya disease in the USA. Neuroepidemiology 40 : 282-287, 2013 https://doi.org/10.1159/000345957
  23. Koton S, Schneider AL, Rosamond WD, Shahar E, Sang Y, Gottesman RF, et al. : Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA 312 : 259-268, 2014 https://doi.org/10.1001/jama.2014.7692
  24. Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, et al. : Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health 1 : e259-e281, 2013 https://doi.org/10.1016/s2214-109x(13)70089-5
  25. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. : Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39 : 42-47, 2008 https://doi.org/10.1161/strokeaha.107.490714
  26. Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, et al. : Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 45 : 315-353, 2014 https://doi.org/10.1161/01.str.0000437068.30550.cf
  27. Lanza G, Ricci S, Setacci C, Castelli P, Novalil C, Pratesi C, et al. : An update on Italian Stroke Organization guidelines on carotid endarterectomy and stenting. Int J Stroke 9 Suppl A100 : 14-19, 2014 https://doi.org/10.1111/ijs.12226
  28. Lee JH, Yang DH, Park HS, Cho Y, Jun JE, Park WH, et al. : Incidence of hypertension in Korea: 5-year follow-up study. J Korean Med Sci 26 : 1286-1292, 2011 https://doi.org/10.3346/jkms.2011.26.10.1286
  29. Lee WK, Oh CW, Lee H, Lee KS, Park H : Factors influencing the incidence and treatment of intracranial aneurysm and subarachnoid hemorrhage: time trends and socioeconomic disparities under an universal healthcare system. J Neurointerv Surg 11 : 159-165, 2019 https://doi.org/10.1136/neurintsurg-2018-013799
  30. Levy EI, Rahman M, Khalessi AA, Beyer PT, Natarajan SK, Hartney ML, et al. : Midterm clinical and angiographic follow-up for the first Food and Drug Administration-approved prospective, single-arm trial of primary stenting for stroke: SARIS (stent-assisted recanalization for acute ischemic stroke). Neurosurgery 69 : 915-920; discussion 920, 2011 https://doi.org/10.1227/NEU.0b013e318222afd1
  31. Levy EI, Siddiqui AH, Crumlish A, Snyder KV, Hauck EF, Fiorella DJ, et al. : First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 40 : 3552-3556, 2009 https://doi.org/10.1161/strokeaha.109.561274
  32. Mackay MT, Wiznitzer M, Benedict SL, Lee KJ, Deveber GA, Ganesan V, et al. : Arterial ischemic stroke risk factors: the international pediatric stroke study. Ann Neurol 69 : 130-140, 2011 https://doi.org/10.1002/ana.22224
  33. Miao W, Zhao PL, Zhang YS, Liu HY, Chang Y, Ma J, et al. : Epidemiological and clinical features of Moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 112 : 199-203, 2010 https://doi.org/10.1016/j.clineuro.2009.11.009
  34. Moon TJ : Light and shadows of the Korean healthcare system. J Korean Med Sci 27 Suppl : S3-S6, 2012 https://doi.org/10.3346/jkms.2012.27.S.S3
  35. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. : Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 : 2197-2223, 2012 https://doi.org/10.1016/S0140-6736(12)61689-4
  36. Park JK, Kim KS, Kim CB, Lee TY, Lee KS, Lee DH, et al. : The accuracy of ICD codes for cerebrovascular diseases in medical insurance claims. Korean J Prev Med 33 : 76-82, 2000
  37. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. : 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49 : e46-e110, 2018 https://doi.org/10.1161/STR.0000000000000158
  38. Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, et al. : Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 372 : 1333-1341, 2015 https://doi.org/10.1056/NEJMoa1406656
  39. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al. : Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363 : 1925-1933, 2004 https://doi.org/10.1016/S0140-6736(04)16405-2
  40. Sacco RL, Kargman DE, Gu Q, Zamanillo MC : Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The northern manhattan stroke study. Stroke 26 : 14-20, 1995 https://doi.org/10.1161/01.str.26.1.14
  41. Setacci C, Argenteri A, Cremonesi A, de Donato G, Galzerano G, Lanza G, et al. : Guidelines on the diagnosis and treatment of extracranial carotid artery stenosis from the Italian society for vascular and endovascular surgery. J Cardiovasc Surg (Torino) 55 : 119-131, 2014
  42. Sivenius J, Tuomilehto J, Immonen-Raiha P, Kaarisalo M, Sarti C, Torppa J, et al. : Continuous 15-year decrease in incidence and mortality of stroke in Finland: the FINSTROKE study. Stroke 35 : 420-425, 2004 https://doi.org/10.1161/01.str.0000110220.63212.59
  43. Stacey A, Toolis C, Ganesan V : Rates and risk factors for arterial ischemic stroke recurrence in children. Stroke 49 : 842-847, 2018 https://doi.org/10.1161/STROKEAHA.117.020159
  44. Wang H, Wang D, Fraser K, Swischuk J, Elwood P : Emergent combined intracranial thrombolysis and carotid stenting in the hyperacute management of stroke patients with severe cervical carotid stenosis. AJNR Am J Neuroradiol 28 : 1162-1166, 2007 https://doi.org/10.3174/ajnr.A0497

Cited by

  1. Short- and long-term mortality after intravenous thrombolysis for acute ischemic stroke : A propensity score-matched cohort with 5-year follow-up vol.100, pp.44, 2021, https://doi.org/10.1097/md.0000000000027652
  2. 성인 모야모야병 환자의 건강행위 이행에 영향을 미치는 요인 vol.51, pp.1, 2020, https://doi.org/10.4040/jkan.20222